1. Home
  2. GEOS vs ELTX Comparison

GEOS vs ELTX Comparison

Compare GEOS & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geospace Technologies Corporation (Texas)

GEOS

Geospace Technologies Corporation (Texas)

SELL

Current Price

$4.63

Market Cap

61.4M

Sector

Industrials

ML Signal

SELL

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

SELL

Current Price

$1.79

Market Cap

63.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GEOS
ELTX
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
63.3M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
GEOS
ELTX
Price
$4.63
$1.79
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $13.67
AVG Volume (30 Days)
83.2K
★ 276.2K
Earning Date
11-19-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.29
EPS
N/A
★ N/A
Revenue
★ $110,803,000.00
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.48
$1.71
52 Week High
$29.89
$16.00

Technical Indicators

Market Signals
Indicator
GEOS
ELTX
Relative Strength Index (RSI) 36.79 31.97
Support Level N/A $1.74
Resistance Level $5.40 $1.97
Average True Range (ATR) 0.15 0.12
MACD 0.02 0.03
Stochastic Oscillator 28.07 25.00

Price Performance

Historical Comparison
GEOS
ELTX

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: